false --12-31 2026 Q1 0001945619 7625755 0 0 1 1 0001945619 2026-01-01 2026-03-31 0001945619 2026-06-23 0001945619 2026-03-31 0001945619 2025-12-31 0001945619 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001945619 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001945619 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001945619 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001945619 2025-01-01 2025-03-31 0001945619 KSEZ:PreferredStockSeriesAMember 2024-12-31 0001945619 KSEZ:PreferredStockSeriesBMember 2024-12-31 0001945619 us-gaap:CommonStockMember 2024-12-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001945619 us-gaap:RetainedEarningsMember 2024-12-31 0001945619 2024-12-31 0001945619 KSEZ:PreferredStockSeriesAMember 2025-12-31 0001945619 KSEZ:PreferredStockSeriesBMember 2025-12-31 0001945619 us-gaap:CommonStockMember 2025-12-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001945619 us-gaap:RetainedEarningsMember 2025-12-31 0001945619 KSEZ:PreferredStockSeriesAMember 2025-01-01 2025-03-31 0001945619 KSEZ:PreferredStockSeriesBMember 2025-01-01 2025-03-31 0001945619 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001945619 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001945619 KSEZ:PreferredStockSeriesAMember 2025-01-01 2025-12-31 0001945619 KSEZ:PreferredStockSeriesBMember 2025-01-01 2025-12-31 0001945619 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-12-31 0001945619 us-gaap:RetainedEarningsMember 2025-01-01 2025-12-31 0001945619 2025-01-01 2025-12-31 0001945619 KSEZ:PreferredStockSeriesAMember 2026-01-01 2026-03-31 0001945619 KSEZ:PreferredStockSeriesBMember 2026-01-01 2026-03-31 0001945619 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001945619 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001945619 KSEZ:PreferredStockSeriesAMember 2025-03-31 0001945619 KSEZ:PreferredStockSeriesBMember 2025-03-31 0001945619 us-gaap:CommonStockMember 2025-03-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001945619 us-gaap:RetainedEarningsMember 2025-03-31 0001945619 2025-03-31 0001945619 KSEZ:PreferredStockSeriesAMember 2026-03-31 0001945619 KSEZ:PreferredStockSeriesBMember 2026-03-31 0001945619 us-gaap:CommonStockMember 2026-03-31 0001945619 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001945619 us-gaap:RetainedEarningsMember 2026-03-31 0001945619 KSEZ:ConsultingRevenueMember 2026-01-01 2026-03-31 0001945619 KSEZ:ProductSalesMember 2026-01-01 2026-03-31 0001945619 KSEZ:TotalRevenueMember 2026-01-01 2026-03-31 0001945619 KSEZ:ConsultingRevenueMember 2025-01-01 2025-03-31 0001945619 KSEZ:ConsultingLaborMember 2026-01-01 2026-03-31 0001945619 KSEZ:ConsultingLaborMember 2025-01-01 2025-03-31 0001945619 KSEZ:CoralInvestmentPartnersMember 2021-09-18 0001945619 KSEZ:CoralInvestmentPartnersMember 2022-06-30 0001945619 KSEZ:CoralInvestmentPartnersMember 2022-06-28 2022-06-30 0001945619 KSEZ:CoralInvestmentPartnersMember 2022-09-14 2022-09-15 0001945619 KSEZ:CoralInvestmentPartnersMember 2022-09-15 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-02-14 2023-02-15 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-03-28 2023-03-29 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-06-27 2023-06-30 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-05-09 2023-05-10 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-06-22 2023-06-29 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-07-04 2023-07-05 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-08-20 2023-08-21 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-11-05 2023-11-06 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-12-13 2023-12-14 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-12-14 0001945619 KSEZ:CoralInvestmentPartnersMember 2024-01-02 0001945619 KSEZ:CoralInvestmentPartnersMember 2023-12-31 0001945619 KSEZ:AdditionalFinancingArrangementsMember 2025-01-01 2025-12-31 0001945619 KSEZ:AdditionalFinancingArrangementsMember 2026-01-01 2026-03-31 0001945619 KSEZ:AdditionalFinancingArrangementsMember 2025-12-31 0001945619 KSEZ:LisaLozinskiMember 2024-09-20 0001945619 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001945619 us-gaap:PreferredStockMember 2026-03-31 0001945619 KSEZ:PrivateOfferingMember 2023-12-14 0001945619 KSEZ:December2023PrivateOfferingMember 2023-12-13 2023-12-14 0001945619 KSEZ:December2023PrivateOfferingMember 2024-01-01 2024-06-30 0001945619 KSEZ:PrivateOfferingMember 2024-03-19 0001945619 KSEZ:March2024PrivateOfferingMember 2024-04-01 2024-06-30 0001945619 KSEZ:March2024PrivateOfferingMember 2024-07-01 2024-07-14 0001945619 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001945619 KSEZ:July2024OfferingMember 2024-07-15 0001945619 KSEZ:July2024OfferingMember 2024-07-16 2025-03-31 0001945619 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-03-31 0001945619 us-gaap:CommonStockMember KSEZ:OneShareholderMember 2025-01-01 2025-03-31 0001945619 us-gaap:SeriesAPreferredStockMember KSEZ:OneShareholderMember 2025-01-01 2025-03-31 0001945619 KSEZ:TwoInvestorRelationsFirmsMember 2025-01-01 2025-03-31 0001945619 KSEZ:SeriesAConvertiblePreferredStockMember 2023-02-28 0001945619 KSEZ:SeriesAConvertiblePreferredStockMember 2024-05-30 2024-05-31 0001945619 us-gaap:CommonStockMember 2024-05-30 2024-05-31 0001945619 us-gaap:SeriesAPreferredStockMember 2024-07-01 2024-09-30 0001945619 KSEZ:SeriesAConvertiblePreferredStockMember 2024-11-17 2024-11-18 0001945619 KSEZ:SeriesAConvertiblePreferredStockMember 2024-12-31 0001945619 KSEZ:SeriesAConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001945619 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001945619 KSEZ:SeriesAConvertiblePreferredStockMember 2025-03-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember 2024-07-13 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2025-01-01 2025-03-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember KSEZ:ConsultingServicesMember 2025-01-01 2025-03-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember 2024-12-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember KSEZ:PreferredBConvertedToCommonStockMember 2025-01-01 2025-03-31 0001945619 us-gaap:CommonStockMember KSEZ:PreferredBConvertedToCommonStockMember 2025-01-01 2025-03-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember 2025-03-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember 2026-03-31 0001945619 KSEZ:SeriesBConvertiblePreferredStockMember 2025-12-31 0001945619 KSEZ:ClassAWarrantsMember 2026-03-31 0001945619 KSEZ:ClassBWarrantsMember 2026-03-31 0001945619 2023-06-01 2023-06-05 0001945619 KSEZ:PreSplitMember 2023-06-05 0001945619 KSEZ:PostSplitMember 2023-06-05 0001945619 KSEZ:PostSplitMember 2023-06-01 2023-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure KSEZ:Integer

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

Or

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to ______

 

Commission file number 000-56478

 

KINETIC SEAS INCORPORATED
(Exact name of registrant as specified in its charter)

 

Colorado   47-1981170

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

  

     

1501 E. Woodfield Rd., Suite 114E

Schaumburg, IL

  60173
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (847) 754-4600

 

 
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
N/A   N/A   N/A

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated Filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes No

 

The number of shares outstanding of the registrant’s common stock as of June 23, 2026,was 60,745,926 shares.

 

 

 

   

 

 

KINETIC SEAS INCORPORATED

QUARTERLY REPORT ON FORM 10-Q

For the Three Months Ended March 31, 2026

 

PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements (unaudited) 4
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 20
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 27
     
Item 4. Controls and Procedures 27
     
PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings 29
     
Item 1A. Risk Factors 29
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
     
Item 3. Defaults Upon Senior Securities 29
     
Item 4. Mine Safety Disclosures 29
     
Item 5. Other Information 29
     
Item 6. Exhibits 30
     
SIGNATURES 31

 

 

 

 

 2 

 

 

PART I – FINANCIAL INFORMATION

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Information contained in this quarterly report on Form 10-Q contains “forward-looking statements.” These forward-looking statements are contained principally in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project” or the negative of these words or other variations on these words or comparable terminology. The forward-looking statements herein represent our expectations, beliefs, plans, intentions or strategies concerning future events, including, but not limited to: our ability to consummate the Merger, as such term is defined below; the continued services of the Custodian as such term is defined below; our future financial performance; the continuation of historical trends; the sufficiency of our resources in funding our operations; our intention to engage in mergers and acquisitions; and our liquidity and capital needs. Our forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking statements will come to pass. Moreover, our forward-looking statements are subject to various known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. These risks, uncertainties and other factors include but are not limited to: the risks of limited management, labor, and financial resources; our ability to establish and maintain adequate internal controls; our ability to develop and maintain a market in our securities; and our ability obtain financing, if and when needed, on terms that are acceptable. Except as required by applicable laws, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

 

As used in this quarterly report on Form 10-Q, “we”, “our”, “us” and the “Company” refer to Kinetic Seas Incorporated. a Colorado corporation unless the context requires otherwise.

 

 

 

 

 

 

 

 

 

 

 3 

 

 

Item 1. Financial Statements.

 

Index to Unaudited Financial Statements

 

    Page
     
FINANCIAL STATEMENTS:    
     
Balances Sheets as of March 31, 2026 (unaudited) and December 31, 2025   5
     
(Unaudited) Statements of Operations for the Three Months Ended March 31, 2026, and March 31, 2025   6
     
(Unaudited) Statements of Changes in Stockholders’ Deficit for the Three Months Ended March 31, 2026, and 2025   7
     
(Unaudited) Statements of Cash Flows for the Three Months Ended March 31, 2026, and 2025   8
     
Notes to the (Unaudited) Interim Financial Statements   9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 4 

 

 

KINETIC SEAS INCORPORATED

BALANCE SHEETS

 

       
   March 31,  December 31,
   2026  2025
   (Unaudited)   
ASSETS          
Current Assets          
Cash  $205,667   $7,767 
Prepaid Expenses       43,750 
Investment as Collateral   572,000     
Total current assets   777,667    51,517 
Right of use assets   45,364    50,543 
Property and equipment, net   36,785    46,243 
Investments   7,847,736    10,460,540 
Total assets  $8,707,552   $10,608,843 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
Current Liabilities          
Accounts payable  $88,325   $201,028 
Accrued liabilities   (10)   540 
Deferred Revenue Current   2,079,000    2,079,000 
Accrued interest   12,623    30,821 
Lease liabilities -short term   20,930    20,930 
Notes payable   602,564    315,000 
Notes payable related parties       239,957 
Total current liabilities   2,803,432    2,887,275 
           
Deferred Revenue-noncurrent   7,449,750    7,969,500 
Non-Current Liabilities   71,900    71,900 
Lease liabilities long term   25,611    30,778 
Total Non-current Liabilities   7,547,261    8,072,178 
Total liabilities   10,350,693    10,959,453 
           
Commitments and contingencies        
           
STOCKHOLDERS' DEFICIT          
Preferred A stock, $0.00001 par value, 50,000,000 shares authorized, 500 and 500 shares issued and outstanding, respectively, as of March 31, 2026 and December 31, 2025        
Preferred B stock, $0.00001 par value, 50,000,000 shares authorized, 4,917 and 11,917 shares issued and outstanding, respectively, as of March 31, 2026 and December 31, 2025   4    4 
Common stock, $0.00001 par value, 200,000,000 shares authorized and 57,145,926 and 52,789,000 shares issued and outstanding, respectively as of March 31, 2026 and December 31, 2025   571    527 
Additional paid-in-capital   5,982,039    5,899,007 
Accumulated deficit   (7,625,755)   (6,250,147)
Total stockholders' deficit   (1,643,141)   (350,609)
Total liabilities and stockholders' deficit  $8,707,552   $10,608,843 

 

Note: Amounts may not foot due to rounding.

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 

 5 

 

 

KINETIC SEAS INCORPORATED

STATEMENTS OF OPERATIONS

(Unaudited)

       
   Three months  Three months
   ended  ended
   March 31,  March 31,
   2026  2025
       
Consulting Revenue  $25,895   $67,871 
Product Sales   519,750     
Cost of sales consulting labor       57,162 
Gross margin   545,645    10,708 
           
Operating expenses          
Selling, general and administrative expenses   210,813    82,490 
Professional fees   133,027    5,422 
Payroll and benefits   19,405    116,440 
Total operating expenses   363,246    204,352 
Gain/Loss from operations   182,399    (193,644)
Other Income (expense):          
Investment Income   98,296     
Interest expense   (53,702)   (30,247)
Gain/Loss on Debt Extinguishment   (1,602,602)    
Total other income and expense   (1,558,007)   (30,247)
Net (loss)  $(1,375,608)  $(223,891)
           
Basic and diluted loss per share  $(0.03)  $(0.01)
           
Weighted average number of shares outstanding:          
Basic and diluted   54,677,089    30,441,500 

 

Note: Amounts may not foot due to rounding.

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 

 6 

 

 

KINETIC SEAS INCORPORATED

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

AS OF MARCH 31, 2025 and MARCH 31, 2026

 

                                              
   Preferred A Stock   Preferred B Stock   Common Stock   Additional Paid In   Accumulated   Total Stockholders’ 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2024   21,100   $    5,500   $    16,329,000   $163   $2,992,676   $(5,014,920)  $(2,022,081)
                                              
Conversion of Preferred A to common stock   (21,100)               21,100,000    211    (211)        
                                              
Conversion of Preferred B to common stock           (5,500)       5,500,000    55    (55)        
                                              
Conversion of common shares to Preferred A   500                (500,000)   (5)   5         
                                              
Shares issued for services                   2,125,000    21    1,062,479        1,062,500 
                                              
Net loss                               (223,891)   (223,891)
                                              
Balance, March 31, 2025   500   $       $    44,554,000   $445   $4,054,894   $(5,238,811)  $(1,183,472)

 

 

 

 

 

 7 

 

 

KINETIC SEAS INCORPORATED

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(continued) 

 

   Preferred A Stock   Preferred B Stock   Common Stock   Additional Paid In   Accumulated   Total Stockholders' 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2024   21,100   $    5,500   $    16,329,000   $163   $2,992,676   $(5,014,920)  $(2,022,081)
                                              
Conversion of Preferred A to common stock   (21,100)               21,100,000    211    (211)        
                                              
Conversion of Preferred B to common stock           (5,500)       5,500,000    55    (55)        
                                              
Conversion of common shares to Preferred A   500                (500,000)   (5)   5         
                                              
Shares issued for services                   8,750,000    88    2,350,163        2,350,251 
                                              
Shares issued for financing fees           9,917    4    400,000    4    264,692        264,696 
                                              
Common stock issued in private placement                   250,000    3    49,998        50,000 
                                              
Shares issued for cash           2,000        610,000    6    204,994        205,000 
                                              
Shares issued for software                   350,000    4    36,746        36,750 
                                              
Net Loss                               (1,235,227)   (1,235,227)
                                              
Balance, December 31, 2025   500   $    11,917   $4    52,789,000   $527   $5,899,007   $(6,250,147)  $(350,609)
                                              
Conversion of Preferred B to common stock           (7,000)       2,600,000    26            26 
                                              
Shares issued for services                   1,100,000    11    32,989        33,000 
                                              
Shares issued for software (issued in prior qtr)                   350,000    4    36,746        36,750 
                                              
Shares issued for financing fees                   556,926    6    35,794        35,800 
                                              
Common stock issued for services (error correction)                   (250,000)   (3)   (22,498)       (22,500)
                                              
Net Loss                               (1,375,608)   (1,375,608)
                                              
Balance, March 31, 2026   500   $    4,917   $4    57,145,926   $571   $5,982,039   $(7,625,755)  $(1,643,141)

 

 

Note: Amounts may not foot due to rounding.

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 8 

 

 

KINETIC SEAS INCORPORATED

STATEMENTS OF CASH FLOWS

(Unaudited)

         
   Three months   Three months 
   ended   ended 
   March 31,   March 31, 
   2026   2025 
Cash flows used in operating activities          
Net (loss) from operations  $(1,375,608)  $(223,891)
Adjustments to reconcile net loss to net cash used in operating activities          
Stock based compensation   47,278     
Gain on the extinguishment of debt   1,602,602     
Depreciation   9,458    9,459 
Investment Income   (98,296)    
Amortization of ROU   5,179     
Changes in assets and liabilities          
Accounts receivable       (5,131)
Lease liability-net   (5,167)   203 
Deferred charge       10,852 
Prepaid Expense   43,750     
Accounts payable   27,225    52,786 
Accrued liabilities   (550)   (101)
Accrued interest   9,815    12,884 
Deferred Revenue   (519,750)    
Cash overdraft       483 
Accrued officer compensation       52,035 
Net cash (used in) operating activities   (254,064)   (90,423)
           
Cash flows (used in) investing activities          
Purchases of property and equipment        
Net cash (used in) investing activities        
           
Cash flows provided by financing activities          
Repayment from related party notes      21,502 
Repayment of notes payable       (1,776)
Proceeds from notes payable   451,964    65,750 
Net cash provided by financing activities   451,964    85,476 
           
Net increase (decrease) in cash   197,900    (4,947)
Cash, beginning of period   7,767    4,947 
Cash, end of period  $205,667   $ 

 

Note: Amounts may not foot due to rounding.

 

The accompanying notes are an integral part of these unaudited financial statements.

 

 

 

 9 

 

 

NOTES TO UNAUDITED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025

 

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Nature of Operations

 

Kinetic Seas Incorporated (the “Company”) was formed on January 3, 2015, as a Colorado corporation with the name ONCO Merger Sub, Inc. On January 5, 2025, the Company merged with Oncology Med, Inc. as part of a holding company reorganization involving Oracle Nutraceuticals Company, under which the Company was the surviving entity in the merger. On January 18, 2015, the Company changed its name to Oncology Med, Inc. On September 16, 2016, the Company changed its name to Bellatora, Inc. On January 19, 2024, the Company changed its name to Kinetic Seas Incorporated.

 

The Company is an Artificial Intelligence (“AI”) consulting, research and development, infrastructure, and software company with a primary focus on GPU Cloud Hosting.

  

By a written consent dated December 14, 2023, the Board of Directors of the Company approved the appointment of Edward Honour, Jeffey Lozinski, Joseph Lehman, and Robert Jackson to the Board of Directors of the Company, and appointed Edward Honour as Chairman (the “New Directors”). At the same time, the Board of Directors approved the issuance of 21,600,000 shares of common stock at $0.001 per share to the New Directors and certain new employees, of which 19,950,000 were acquired by the New Directors. In addition, the Board of Directors also approved a private offering of 10,000,000 shares of common stock at $0.05 per share. An affiliate of a New Director purchased the initial 1,000,000 shares in this offering. As a result of both transactions, the New Directors and their affiliates acquired an aggregate of 20,950,000 Shares of common stock, which constituted approximately 84% of issued and outstanding common shares of the Company at the time.

 

The appointment of the New Directors to the Company’s board, and the sale to the New Directors of a controlling interest in the Company, were made to enable the Company to enter the business of artificial intelligence hosting, research & development, and consulting. Before the change in control to the New Directors, the Company was a shell company.

 

The Company’s accounting year-end is December 31.

 

 

 

 

 

 10 

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

  

Basis of Presentation

 

The financial statements of the Company have been prepared in accordance with GAAP. This basis of accounting involves the application of accrual accounting and consequently, revenues and gains are recognized when earned, and expenses and losses or recognized when incurred.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of accrued liabilities and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to revenue recognition, valuation of accounts receivable, and the allowance for doubtful accounts, inventories, and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

  

Revenue Recognition and Cost of Consulting Labor

 

The Company adopted Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), using the modified retrospective method applied to those contracts that were not completed as of January 1, 2018.

 

The Company will recognize revenue in accordance with Accounting Standards Codification No. 606, “Revenue from Contracts with Customers” (“ASC606”). ASC 606 directs entities to recognize revenue when the promised goods or services are transferred to the customer. The amount of revenue recognized should equal the total consideration an entity expects to receive in return for the goods or services. The Financial Accounting Standards Board (FASB) created a five-step approach that entities should apply when determining the amount and timing of revenue recognition:

 

Step 1: Identify the contract with a customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.

 

During the three months ended March 31, 2026, the Company generated consulting revenue of $25,895 and product sales revenue of $519,750, resulting in total revenue of $545,645, compared to consulting revenue of $67,871 during the three months ended March 31, 2025. Cost of consulting labor was $0 for the three months ended March 31, 2026, compared to $57,162 for the three months ended March 31, 2025. As a result, gross margin was $545,645 for the three months ended March 31, 2026, compared to $10,708 for the comparable prior-year period.

 

The Company did not record any direct software development costs in cost of sales during the three months ended March 31, 2026. Software development expenditures are included within Selling, General and Administrative expenses because the underlying software, code base, technology components, and intellectual property are developed for use across multiple current and prospective customer engagements and future commercial opportunities. Management believes these costs cannot be reasonably allocated to any specific product sale, customer contract, or revenue stream, as the developed technologies may be utilized in numerous current and future projects, some of which may ultimately result in customer product sales while others may not. Accordingly, all software development costs are classified as general and administrative expenses rather than direct costs of revenue.

 

 

 

 11 

 

 

Cash and Cash Equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2026 and December 31, 2025, the Company had cash and cash equivalents of $205,667 and $7,767, respectively.

 

Stock-based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the FASB Accounting Standards Codification for disclosure about Stock-Based Compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

 

Income taxes

 

The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

 

The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.

 

On Dec. 18, 2019, the Financial Accounting Standards Board (FASB) released Accounting Standards Update (ASU) 2019-12, which affects general principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. The FASB has stated that the ASU is being issued as part of its Simplification Initiative, which is meant to reduce complexity in accounting standards by improving certain areas of generally accepted accounting principles (GAAP) without compromising information provided to users of financial statements. The Company adopted this guidance on January 1, 2021, which had no impact on the Company’s financial statements.

 

 

 

 12 

 

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share.” Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

Recent Accounting Pronouncements

 

There have been no new or material changes to the significant accounting policies discussed in the Company’s audited financial statements in its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 as filed with the SEC on May 29, 2026, that are of significance, or potential significance, to the Company.

 

NOTE 3 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve months following the date of these financial statements.

 

The Company has incurred significant operating losses since inception. As of March 31, 2026, the Company had an accumulated deficit of approximately $7.63 million and a working capital deficit of approximately $2.03 million. In addition, the Company reported a net loss of $1,375,608 for the three months ended March 31, 2026.

 

The Company does not currently expect that cash generated from operations will be sufficient to fund its anticipated operating requirements. These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that these financial statements are issued.

 

Management's plans to alleviate this substantial doubt include continued efforts to raise capital through private placements of equity securities, debt financing arrangements, strategic partnerships, and other financing alternatives. The Company has historically been successful in obtaining funding from investors and lenders and continues to evaluate additional sources of capital to support operations, product development, commercialization efforts, and working capital requirements. However, there can be no assurance that such financing will be available on acceptable terms, if at all.

 

The accompanying financial statements have been prepared assuming the Company will continue as a going concern and do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

 

 

 

 13 

 

 

NOTE 4 – ACCRUED LIABILITIES

 

As of March 31, 2026 and December 31, 2025, the Company had accrued liabilities of $(10) and $540, respectively.

 

The decrease in accrued liabilities during the three months ended March 31, 2026 reflects the settlement, adjustment, and reclassification of accrued obligations recorded in prior periods. As of March 31, 2026, substantially all accrued liabilities had been satisfied, resulting in an immaterial net debit balance.

 

The Company also maintains a liability related to certain historical cash receipts associated with cigar sales recorded during the year ended December 31, 2021. Because the Company was unable to substantiate revenue recognition for these receipts in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers, the amounts were recorded as a liability rather than recognized as revenue. This liability will remain on the Company's balance sheet until management determines that the obligation has been resolved or the applicable statute of limitations has expired.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

On September 18, 2021, the Company entered into a $30,000 Promissory Note Agreement at 24% interest with Coral Investment Partners (“CIP”). CIP’s managing director is Erik Nelson who was formerly the CEO of the Company. On June 30, 2022, CIP increased its Promissory Note to $50,000 by funding another $20,000 loan to the Company. Subsequently, CIP made an additional loan of $40,000 on September 15, 2022, to bring the total loan balance to $90,000 plus $21,674 in accrued interest. During the fiscal year ended December 31, 2023, CIP made additional loan amounts of $5,000 on February 15, 2023, $22,000 on March 29, 2023, $11,000 on June 30, 2023, $10,000 on May 10, 2023, $4,000 on June 29, 2023, $10,000 on July 5, 2023, $15,000 on August 21, 2023 and $15,000 on November 6, 2023.

 

On December 14, 2023, the Company and CIP agreed to convert $50,000 of indebtedness under the Promissory Note into 1,000,000 shares of the Company’s common stock at $0.05 per share. Also after December 14, 2023, the interest rate was reduced to 12% for the period from December 14, 2023, through December 31, 2023. Effective January 1, 2024, the interest rate became 10%.

 

The conversion of debt into stock reduced the balance owed on the Promissory Note to $182,000 of principal and $11,098 of interest as of December 31, 2023.

 

During the three months ended March 31, 2026, the Company entered into additional financing arrangements that increased outstanding notes payable by approximately $451,964. In addition, the Company settled certain outstanding debt obligations through the transfer of investment securities and the issuance of common stock, resulting in a reduction of both principal and accrued interest balances. As a result of these transactions, notes payable from related party decreased from $315,000 at December 31, 2025 to Nil at March 31, 2026 and accrued interest from related party decreased from $22,753 at December 31, 2025 to Nil at March 31, 2026. As of December 31, 2025, the Company had notes payable of $315,000 and accrued interest of $22,853 from related party.

 

Interest expense of $53,702 was recognized during the three months ended March 31, 2026 in accordance with the terms of the Company's financing agreements. The Company continues to rely on a combination of debt financing, equity issuances, and strategic financing arrangements to support its operations and growth initiatives.

 

 

 

 

 14 

 

 

On September 20, 2024, Lisa Lozinski, the spouse of a Company director, loaned the Company $50,000 pursuant to a promissory note bearing interest at 18% per annum. The note required monthly interest payments and included certain equity-related provisions. During the three months ended March 31, 2026, the Company continued to make required interest payments under the agreement. As of March 31, 2026, no amounts were classified as notes payable to related parties on the Company's balance sheet.

 

During the three months ended March 31, 2026, Jeffrey Lozinski, an officer of the Company, continued to provide operational support to the Company. As of March 31, 2026, the Company had no balance recorded as notes payable to related parties.

 

As of March 31, 2026 and December 31, 2025, the Company had 500 shares of Series A Convertible Preferred Stock issued and outstanding.

 

As of March 31, 2026 and December 31, 2025, the Company had 4,917 and 11,917 shares of Series B Preferred Stock issued and outstanding, respectively. The decrease in Series B Preferred Stock during the three months ended March 31, 2026 resulted from the conversion of 7,000 shares of Series B Preferred Stock into 2,600,000 shares of the Company's common stock in accordance with the terms of the Series B Preferred Stock.

 

NOTE 6 – EQUITY

 

The Company is authorized to issue 200,000,000 shares of common stock, par value $0.00001 per share, and 10,000,000 shares of preferred stock, par value $0.00001 per share.

 

As of March 31, 2026, the Company had 57,145,926 shares of common stock issued and outstanding, compared to 52,789,000 shares outstanding as of December 31, 2025.

 

During the three months ended March 31, 2026, the Company issued an aggregate of 4,356,926 shares of common stock. The issuances were primarily related to capital raising activities, debt conversions, financing fees, and other corporate purposes. All shares were issued pursuant to applicable exemptions from registration under the Securities Act of 1933, as amended.

 

Issuance of Common Stock

 

On December 14, 2023, the Board of Directors approved an offering of up to 10,000,000 shares of common stock in a private offering to accredited investors for $0.05 per share. Prior to the year-end, the Company issued 1,000,000 shares in an offering for an investment of $50,000. During the six months ended June 30, the Company completed the private placement by issuing 9,000,000 shares at $0.05 per share which generated $450,000 in proceeds.

 

On March 19, 2024, the Board of Directors approved an offering of up to 6,000,000 shares of common stock in a private offering to accredited investors for $0.05 per share. During the three months ended June 30, 2024, the Company issued 4,104,000 shares in the offering and raised $205,200 proceeds. The offering of 6,000,000 shares continued until July 14, 2024. During the period from July 1, 2024, through July 14, 2024, the Company sold 197,000 common shares in the offering and raised $9,850 in proceeds.

 

During the six months ended June 30, 2024, the Company also issued 40,000 shares for services rendered valued at $2,000.

 

 

 

 

 15 

 

 

On July 15, 2024, the Company commenced a new offering of 2,000,000 shares at a price of $0.50 per share. During the period from July 15, 2024, to March 31, 2025, the Company sold 242,000 common shares in the offering and raised $121,000 in proceeds.

 

During the three months ended March 31, 2025, holders of Series A and Series B Preferred Stock converted all outstanding preferred shares into an aggregate of 26,600,000 shares of the Company's common stock. In addition, one shareholder exchanged 500,000 shares of common stock for 500 shares of Series A Preferred Stock. During the same period, the Company issued 2,125,000 shares of common stock to two investor relations firms for services rendered.

 

As of March 31, 2026, the Company had 500 shares of Series A Preferred Stock outstanding and 4,917 shares of Series B Preferred Stock outstanding. As of March 31, 2026, the Company had 57,145,926 shares of common stock issued and outstanding, compared to 52,789,000 shares outstanding as of December 31, 2025.

 

During the three months ended March 31, 2026, the Company issued shares of common stock in connection with the conversion of Series B Preferred Stock, the settlement of interest obligations, compensation for services, financing fees, and other corporate financing activities. The Company also issued common stock in connection with previously approved financing and capital formation transactions.

 

The decrease in Series B Preferred Stock during the quarter resulted from the conversion of 7,000 shares of Series B Preferred Stock into 2,600,000 shares of common stock in accordance with the terms of the Company's Certificate of Designation. These transactions, together with other equity issuances completed during the period, increased the Company's issued and outstanding common shares to 57,145,926 as of March 31, 2026.

 

Conversions completed in prior periods remain reflected in the Company's capital structure and stockholders' equity accounts as of March 31, 2026.

 

Issuance of Preferred A Stock

 

In February 2023, the Board of Directors approved the issuance of one series of preferred stock, the Series A Convertible Preferred Stock (the “Series A Preferred”), for 100,000,000 shares, of which 19,250 shares were issued on May 31, 2024, in exchange for 19,250,000 shares of common stock. During the three months ended September 30, 2024, the Company issued 150 shares of Series A Preferred as a financing fee. On November 18, 2024, 1,700,000 common shares were converted to 1,700 Series A Preferred. As of December 31, 2024, there were 21,100 shares of Series A Preferred outstanding.

 

During the three months ended March 31, 2025, the 21,100 shares of Series A Preferred Stock then outstanding were converted into 21,100,000 shares of the Company's common stock. In addition, 500,000 shares of common stock were exchanged for 500 shares of Series A Preferred Stock. As a result, 500 shares of Series A Preferred Stock were outstanding as of March 31, 2025.

 

No additional conversions of Series A Preferred Stock occurred during the three months ended March 31, 2026. Accordingly, as of March 31, 2026 and December 31, 2025, the Company had 500 shares of Series A Preferred Stock issued and outstanding.

 

 

 

 

 

 16 

 

 

The Series A Preferred has the following rights:

 

Dividends: Each share of Series A Preferred is entitled to receive non-cumulative dividends equal to the amount of dividends that the holder of such share would have received if such share of Series A Preferred were converted into shares of common stock immediately prior to the record date of the dividend declared on the common stock.

 

Liquidation Preference: The Series A Preferred Stock is entitled to receive, prior to any distribution to any junior class of securities, an amount equal to $0.01 per share, plus any accrued but unpaid dividends, as a liquidation preference before any distribution may be made to the holders of any junior security, including the common stock.

 

Voting Rights: Each holder of Series A Preferred Stock shall vote with holders of the common stock upon any matter submitted to a vote of shareholders, in which event it shall have the number of votes equal to the number of shares of common stock into which such share of Series A Preferred Stock would be convertible on the record date for the vote or consent of shareholders. 

 

Voluntary Conversion Rights: Each share of Series A Preferred Stock is convertible into 1,000 shares of common stock.

 

Mandatory Conversion Rights: The Company may convert all outstanding shares of Series A Preferred Stock into common stock, at the same ratio as the voluntary conversion rights held by the holders, at any time that there are less than 200,000 shares of Series A Preferred Stock outstanding.

 

Rank: The Series A Preferred ranks senior to the common stock and any other class or series of preferred stock that may be authorized and which is designated as junior to the Series A Preferred Stock.

 

Issuance of Preferred B Stock

 

On July 13, 2024, the Board of Directors approved the issuance of a second series of preferred stock, the Series B Convertible Preferred Stock (the “Series B Preferred”), for 10,000,000 shares. During the three months ended March 31, 2025, the Company issued 4,000 shares of Series B Preferred for cash consideration of $200,000, and 1,500 shares of Series B Preferred for consulting services valued at $750,000. As of December 31, 2024 there were 5,500 shares of Series B Preferred outstanding.

 

During the three months ended March 31, 2025, the 5,500 shares of Series B Preferred Stock then outstanding were converted into 5,500,000 shares of the Company's common stock. As a result, no shares of Series B Preferred Stock were outstanding as of March 31, 2025.

 

Subsequent to those conversions, the Company issued additional shares of Series B Preferred Stock. As of March 31, 2026 and December 31, 2025, the Company had 4,917 and 11,917 shares of Series B Preferred Stock issued and outstanding, respectively.

 

 

 

 

 

 17 

 

 

The Series B Preferred has the following rights:

 

Dividends: Each share of Series B Preferred is entitled to receive non-cumulative dividends equal to the amount of dividends that the holder of such share would have received if such share of Series B Preferred were converted into shares of common stock immediately prior to the record date of the dividend declared on the common stock.

 

Liquidation Preference: The Series B Preferred Stock is entitled to receive, prior to any distribution to any junior class of securities, an amount equal to $0.01 per share, plus any accrued but unpaid dividends, as a liquidation preference before any distribution may be made to the holders of any junior security, including the common stock.

 

Voting Rights: The Series B Preferred Stock does not have the right to vote on any matter submitted to a vote of shareholders, but is entitled to notice of any shareholder meeting or any action proposed to be taken by shareholders in lieu of a meeting.

 

Voluntary Conversion Rights: Each share of Series B Preferred is convertible into 1,000 shares of common stock, provided that no holder of Series B Preferred may convert its shares into common stock to the extent the holder would be the beneficial owner of more than 4.99% of the Company’s common stock immediately after the conversion, and further provided that the holder has the right to waive this limitation on at least 61 days prior notice to the Company.

 

Mandatory Conversion Rights: The Company may convert all outstanding shares of Series B Preferred Stock into common stock, at the same ratio as the voluntary conversion rights held by the holders, at any time that there are less than 200,000 shares of Series B Preferred Stock outstanding.

 

Rank: The Series B Preferred ranks senior to the common stock and any other class or series of preferred stock that may be authorized and which is designated as junior to the Series B Preferred. The Series B Preferred ranks junior to the Series A Preferred.

  

On July 24, 2024, the Company changed its Articles of Incorporation and filed a Certificate of Designation to create 10,000,000 shares of Series B Convertible Preferred Stock. The Series B preferred shares are junior to Series B Preferred Stock and have the same rights as Series A Preferred with one exception. Series B preferred holders cannot hold in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the conversion.

 

Warrants

 

The Company has outstanding 500,000 Class A Warrants and 500,000 Class B Warrants. The Class A Warrants are exercisable at $1.00 per share until June 20, 2026, and the Class B Warrants are exercisable at $2.50 per share until June 20, 2026. The Class A and B Warrants are exercisable at any time by the holder on a cash or cashless basis, provided that the holder may not exercise the warrants if the holder would own more than 4.99% of the Company immediately following the exercise, provided that the holder has the right to increase such percentage to no more than 9.99% upon at least 61 days prior written notice to the Company.

 

Reverse Stock Split

 

On June 5, 2023, the Company effected a 1 for 50,000 reverse split immediately followed by a 500 to 1 forward split. The net impact was a reverse split of 1 for 100. At that time the split was declared the Company had 140,790,867 shares outstanding. Post split there were 3,046,000 shares outstanding. As a result of FINRA policies regarding beneficial ownership of odd lot holders, the Company issued approximately 1,000,000 in excess of the amounts anticipated by the split. This split has been retroactively applied in the financial statement to all prior periods, and all reference to share counts in this report reflect post-split amounts unless specifically stated otherwise.

 

 

 

 18 

 

 

NOTE 7 – NOTES PAYABLE

 

As of March 31, 2026, the Company had notes payable totaling $602,564, bearing interest rates ranging from 8% to 20%, net of a discount of $35,936, along with accrued interest of $12,623. During the three-month period ended March 31, 2026, the Company secured additional financing, increasing its outstanding notes payable by approximately $451,964. The Company also settled certain debt obligations by transferring investment securities and issuing common stock, which reduced both the principal and accrued interest balances. Accrued interest rose from $7,322 at December 31, 2025 to $12,623 as of March 31, 2026.

 

As of March 31, 2025, the Company had a total of $295,138 in short-term notes payable to ten different noteholders at interest rates varying from 10% to 36%. Approximately, $110,000 of these notes were past due and continue to accrue interest.

 

NOTE 8 – LEASES

 

During 2024, the Company entered into a non-cancellable four year lease for which it recorded a right-of-use asset and liability based on the present value of the lease payments in the amount of $82,897 using a term of 47 months and a discount rate of 12.00%.

 

The weighted average remaining lease term is 24 months and the weighted average discount rate is 12%. Operating lease expense for the three months ended March 31, 2026 was approximately $6,680.

 

Total lease payments under our non-cancellable leases as of March 31, 2026 were as follows:

    
Year 2026 Rem  $20,066 
Year 2027   27,496 
Year 2028   7,050 
Total   54,612 
Imputed interest   8,071 
Lease liability  $46,541 

 

NOTE 9 – SUBSEQUENT EVENTS

 

In accordance with ASC 855-10 the Company has performed an evaluation of subsequent events from March 31, 2026 through June 24, 2026, the date the financial statements were issued. Based on the evaluation, the Company did not identify and subsequent events that would have required adjustment or disclosure in the financial statements.

 

 

 

 

 

 

 

 

 

 

 

 

 19 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Plan of Operation

 

From January 1, 2023, to December 14, 2023, the Company had no operations or revenues from a continuing business other than the general and administrative expenditures related to running the Company.

 

On December 14, 2023, our Board of Directors approved the appointment of Edward Honour, Jeffrey Lozinski, Joseph Lehman, and Robert Jackson to the Board of Directors of the Company, and appointed Edward Honour as Chairman (the “New Directors”). Erik Nelson remained a director of the Company. At the same time, the Board of Directors approved the issuance of 21,600,000 shares of common stock in the Company’s offering at $0.001 per share, of which 19,950,000 were acquired by the New Directors and the remainder were acquired by new employees. In addition, the Board of Directors also approved a private offering of 10,000,000 shares of common stock at $0.05 per share, and the spouse of a New Director purchased the initial 1,000,000 shares in such an offering. As a result of both transactions, the New Directors and their affiliates acquired an aggregate of 20,950,000 Shares of common stock in the Company, which is control of a majority of the issued and outstanding common shares of the Company at the time.

 

On December 14, 2023, the Board of Directors approved a resolution to enter the business of artificial intelligence hosting, research & development, and consulting (collectively, “AI”), and since has entered into a number of contracts and raised a material amount of capital from the private placement of its common stock to capitalize the business. As a result, the Company believes it no longer qualifies as a shell company.

 

In December 2023, following the change to the composition of our Board of Directors on December 14, 2023, we began implementing our business plan. We generated our first consulting revenue in the three months ended March 31, 2024.

 

The Company's artificial intelligence business is focused on AI-enabled software consulting, custom software development, AI implementation services, and the development of proprietary AI-powered solutions. Rather than concentrating on infrastructure and educational services, the Company currently focuses on helping businesses identify, plan, and implement software and artificial intelligence initiatives that improve operational efficiency and create new business opportunities.

 

The Company secures clients through its proprietary Skilliks™ platform, which is designed to evaluate a client's software development and technology requirements and create comprehensive development strategies. Skilliks™ utilizes artificial intelligence to identify opportunities for automation, workflow optimization, software modernization, and the incorporation of AI-powered features that can enhance business operations and customer engagement.

 

The Company's consulting and development services assist organizations in designing, developing, and deploying custom software applications and AI-enabled solutions. Through these engagements, the Company helps clients integrate emerging AI technologies into existing business processes while developing long-term technology roadmaps aligned with each client's strategic objectives.

 

In addition to its consulting activities, the Company is developing comprehensive AI-powered voice-agent solutions for the hospitality industry. These solutions are intended to automate customer interactions, streamline operations, and improve customer experiences for hospitality and food service businesses.

 

The Company is also pursuing software development and artificial intelligence opportunities through its strategic relationship with Sagtec Global Limited. Pursuant to this relationship, the Company is collaborating on the development of software and AI solutions for deployment throughout Southeast Asia. Sagtec currently serves more than 13,000 food and beverage locations through its point-of-sale technology platform and has secured a five-year license to develop software and AI projects within the region. The Company believes this relationship provides a significant opportunity to expand the adoption of its AI-enabled solutions across a large and established customer base.

 

 

 

 20 

 

 

Results of Operations

 

Comparison of Results of Operations for the Three Months Ended March 31, 2026 and 2025.

 

Revenues

 

During the three months ended March 31, 2026 and 2025, the Company generated consulting revenue of $25,895 and $67,871, respectively. In addition, during the three months ended March 31, 2026, the Company recognized product sales revenue of $519,750 related to the satisfaction of performance obligations associated with previously deferred customer contracts. Total revenue for the three months ended March 31, 2026 and 2025 was $545,645 and $67,871, respectively.

 

During the three months ended March 31, 2026 and 2025, the cost of consulting labor incurred to generate consulting revenue was $0 and $57,162, respectively. The Company did not record any direct costs of product sales during the three months ended March 31, 2026. Software development expenditures are included within Selling, General and Administrative expenses because the underlying software, artificial intelligence models, code base, and technology infrastructure are developed for use across multiple current and prospective customer engagements and future commercialization opportunities. Management does not allocate these costs to specific customer contracts or product sales because the technologies developed are utilized across numerous current and future projects and may support multiple revenue-generating activities. As a result, gross profit for the three months ended March 31, 2026 was $545,645, compared to $10,709 for the three months ended March 31, 2025.

 

Operating Expenses

 

During the three months ended March 31, 2026, the Company incurred operating expenses of $363,246, compared to $204,352 during the three months ended March 31, 2025. The increase in operating expenses was primarily attributable to higher professional fees, consulting expenses, public company compliance costs, commissions, investor relations activities, and other administrative expenses associated with the Company's growth initiatives, financing activities, and expansion of operations.

 

Selling, general and administrative expenses increased to $210,813 during the three months ended March 31, 2026, compared to $82,490 during the comparable prior-year period. Professional fees increased to $133,027 from $5,422, reflecting increased legal, accounting, consulting, transfer agent, SEC reporting, and other public company compliance costs. Payroll and benefits were $19,405 for the three months ended March 31, 2026, compared to $116,440 for the three months ended March 31, 2025.

 

The Company includes all software development expenditures within Selling, General and Administrative expenses. Management believes these costs are not directly attributable to any specific customer contract, product sale, or revenue stream because the Company's software platforms, artificial intelligence models, code libraries, applications, and related technology infrastructure are developed for use across multiple current and prospective customer engagements and future commercialization opportunities. Accordingly, no software development costs are classified as direct costs of revenue.

 

The Company expects operating expenses, including selling, general and administrative expenses, software development expenditures, professional fees, payroll and benefits, investor relations costs, public company compliance expenses, and other administrative expenses, to remain significant as the Company continues to expand its operations, pursue strategic growth opportunities, develop proprietary technology, and satisfy its reporting obligations as a public company. The Company may also incur additional expenses related to financing activities, business development initiatives, strategic partnerships, and the hiring of additional personnel as operations expand.

 

 

 

 21 

 

 

Other (Expense)

 

During the three months ended March 31, 2026, the Company recorded total other expense of $1,558,007, compared to $30,247 during the three months ended March 31, 2025. Other income (expense) during the 2026 period consisted primarily of a loss on debt extinguishment of $1,602,602, partially offset by investment income of $98,296, and interest expense of $53,702.

 

The increase in other expense during the three months ended March 31, 2026 was primarily attributable to transactions involving the settlement and restructuring of outstanding indebtedness, which resulted in a significant non-cash loss on debt extinguishment. These charges were partially offset by investment income earned during the period. The Company also continued to incur interest expense on its outstanding borrowings.

 

Management believes that a substantial portion of the increase in other expense for the three months ended March 31, 2026 was attributable to non-cash debt extinguishment and financing-related transactions that are not representative of the Company's recurring operating activities.

 

Net (Loss)

 

As a result of the foregoing, during the three months ended March 31, 2026, the Company incurred a net loss of $(1,375,608), or $(0.03) per basic and diluted share, compared to a net loss of $(223,891), or $(0.01) per basic and diluted share during the three months ended March 31, 2025.

 

The increase in net loss during the three months ended March 31, 2026 was primarily attributable to a non-cash loss on debt extinguishment of $1,602,602, increased operating expenses associated with the Company's growth initiatives, public company compliance activities, professional fees, and administrative expenses. These increases were partially offset by higher revenues recognized during the period, including product sales revenue recognized from the satisfaction of performance obligations associated with previously deferred customer contracts, as well as investment income of $98,296 recognized during the period.

 

Liquidity and Capital Resources

 

As of March 31, 2026, the Company had cash of $205,667.

 

During the three months ended March 31, 2026, the Company incurred a net loss of $(1,375,608).

 

Cash flows used in operating activities were $(254,064) for the three months ended March 31, 2026. Cash used in operating activities was primarily attributable to expenditures associated with operating activities, software development, professional fees, public company compliance costs, financing-related expenses, and changes in working capital accounts. Although the Company recognized revenue of $545,645 during the period, including $519,750 recognized from the satisfaction of performance obligations associated with previously deferred customer contracts, operating cash flows were impacted by ongoing business operations, technology development, and corporate infrastructure costs. Operating cash flows were partially offset by non-cash items, including a $1,602,602 loss on debt extinguishment, depreciation, amortization of right-of-use assets, stock-based compensation, and other non-cash adjustments reflected in the reconciliation of net loss to net cash used in operating activities.

 

 

 

 22 

 

 

Cash flows used in investing activities were $0 for the three months ended March 31, 2026 and $0 for the three months ended March 31, 2025.

 

Cash flows provided by financing activities were primarily attributable to proceeds received from financing arrangements and equity issuances during the three months ended March 31, 2026. During the period, the Company obtained additional funding through debt financing and capital raising transactions to support operations, working capital requirements, software development activities, commercialization efforts, and corporate growth initiatives.

 

Management intends to fund its working capital requirements through a combination of existing cash resources, revenues generated from operations, strategic commercial relationships, and future issuances of debt and equity securities. The Company's working capital requirements are expected to increase as it continues to expand its artificial intelligence, software development, cloud infrastructure, and commercialization activities.

 

Based on its current operating plan, the Company does not have sufficient internally generated cash flow to fund operations over the next twelve months. The Company requires additional capital to execute its business strategy and support future growth initiatives. There can be no assurance that the Company will be successful in obtaining additional financing on acceptable terms, or at all. If additional financing is not available when required, the Company may be forced to delay, reduce, or eliminate certain operating, development, commercialization, or strategic initiatives.

 

Additional issuances of equity securities or securities convertible into equity may result in substantial dilution to existing stockholders. Such securities may also contain rights, preferences, or privileges senior to those of the Company's common stock. Furthermore, debt financing may impose restrictive covenants and other obligations on the Company. If adequate capital is not available on acceptable terms, the Company's ability to pursue new business opportunities, develop products, expand operations, and achieve its strategic objectives could be materially adversely affected.

 

The Company expects to continue incurring operating losses in the near term as it invests in software development, artificial intelligence technologies, commercialization efforts, growth initiatives, and public company compliance activities. Because the Company's software platforms, artificial intelligence models, applications, code libraries, and related technology infrastructure are developed for use across multiple current and prospective customer engagements and future commercial opportunities, software development expenditures are included within Selling, General and Administrative expenses rather than cost of sales. The Company's future success will depend on its ability to generate sustainable revenues, manage growth effectively, secure additional financing when necessary, attract and retain qualified personnel, develop and commercialize its technology solutions, and successfully execute its business strategy. There can be no assurance that the Company will successfully achieve these objectives.

 

 

 

 

 

 

 23 

 

 

Critical Accounting Estimates

 

General

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations is based upon our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates, assumptions, and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

We describe in this section certain critical accounting policies that require us to make significant estimates, assumptions, and judgments. An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are uncertain at the time the estimate is made and if different estimates that reasonably could have been used, or changes in the accounting estimates that are reasonably likely to occur periodically, could materially impact the financial statements. Management believes the following critical accounting policies reflect its most significant estimates and assumptions used in the preparation of the financial statements. For further information on the critical accounting policies, see Note 1 of the Financial Statements.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”), which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

 

 

 

 

 24 

 

 

Cash and cash equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents.

 

Stock-based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the FASB ASC for disclosure about stock-based compensation. This section requires a public entity to measure the cost of employee and non-employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which service is provided. No compensation cost is recognized for equity instruments for which service is not provided or rendered.

 

Related party transactions

 

The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. In accordance with ASC 850, the Company’s financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business, as well as transactions that are eliminated in the preparation of financial statements.

 

Net Loss per Share

 

Net loss per common share is computed in accordance with ASC Topic 260, "Earnings per Share." Basic net loss per common share is calculated by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is calculated by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period, adjusted for the assumed conversion or exercise of potentially dilutive securities when such effect is dilutive.

 

For the three months ended March 31, 2026 and 2025, diluted net loss per share was equal to basic net loss per share because the Company reported a net loss for each period and the inclusion of potentially dilutive securities would have been anti-dilutive. Accordingly, all potentially dilutive securities were excluded from the computation of diluted net loss per share.

 

Potentially dilutive securities outstanding as of March 31, 2026 included 500 shares of Series A Convertible Preferred Stock, 4,917 shares of Series B Preferred Stock, and certain debt and financing instruments that may be convertible into or exercisable for shares of the Company's common stock. Because the effect of these securities would have been anti-dilutive, they were excluded from the calculation of diluted net loss per share for the three months ended March 31, 2026 and 2025.

 

 

 

 

 25 

 

 

Income Taxes

 

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between depreciation which is deductible for tax purposes prior to being deductible for book purposes. The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes also are recognized for operating losses that are available to offset future taxable income.

 

From time to time, the Company may have differences in computing the book and tax bases of property and equipment; reserves for bad debts; capitalized overhead included in inventories; bonus plan payables, and accrued wages to shareholders/employees. Deferred tax expense or benefit is the result of the changes in the deferred tax assets, net of the valuation reserve, and liabilities.

 

The Company accounts for income taxes in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 740 (“FASB ASC 740”), Income Taxes, which clarifies the accounting and disclosure requirements for uncertainty in tax positions. It requires a two-step approach to evaluate tax positions and determine if they should be recognized in the financial statements. The two-step approach involves recognizing any tax positions that are “more likely than not” to occur and then measuring those positions to determine if they are recognizable in the financial statements. Management regularly reviews and analyzes all tax positions and has determined that no uncertain tax positions requiring recognition have occurred.

 

In general, the Company’s income tax returns are subject to examination by the taxing authorities for six years after they were filed. The Company has not filed any tax returns.

 

Segment Reporting

 

We operate in a single operating segment and a single reportable segment focused on artificial intelligence consulting, software development, AI platform licensing, and related services. Operating segments are defined as components of an enterprise for which separate financial information is regularly reviewed by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. The Company’s chief executive officer serves as the CODM and evaluates performance and allocates resources based on consolidated financial information. Because the Company operates as a single operating and reportable segment, all financial segment information required by ASC 280 is included in the consolidated financial statements.

 

 Recent Accounting Pronouncements

 

All other newly issued accounting pronouncements, but not yet effective, have been deemed either immaterial or not applicable.

 

Off-Balance Sheet Arrangements

 

None.

  

 

 

 

 

 26 

 

 

Item 3. Quantitative And Qualitative Disclosures About Market Risk.

 

As a smaller reporting company, we are not required to provide the information called for by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures.

 

Our management is responsible for establishing and maintaining a system of “disclosure controls and procedures” (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management has concluded that its disclosure controls were effective as of March 31, 2025.

 

Management’s Report on Internal Control over Financial Reporting.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

 

  · pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
     
  · provide reasonable assurance that transactions are recorded as necessary to permit preparation of  financial statements in accordance with generally accepted accounting principles and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
     
  · provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness in future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate.

 

 

 

 27 

 

 

Our management assessed the effectiveness of our internal control over financial reporting based on the parameters set forth above and has concluded that as of March 31, 2025, our internal control over financial reporting was not effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles as a result of the following material weaknesses:

 

  · The Company does not have written documentation of our internal control policies and procedures.

 

We plan to rectify these weaknesses by establishing written policies and procedures for our internal control of financial reporting and hiring additional accounting personnel.

 

Changes in Internal Control over Financial Reporting.

 

Since our prior fiscal year ended on December 31, 2025, we have concluded that some of our internal control deficiencies have been remediated. Specifically, we previously identified insufficient segregation of duties within the accounting function, and overreliance on outside financial consulting for financial reporting as internal control weaknesses. With the recent addition of experienced officers and other employees, we no longer consider these issues to be internal control weaknesses.

 

 

 

 

 

 

 

 

 

 

 28 

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The Company may be involved in certain legal proceedings that arise from time to time in the ordinary course of its business. Legal expenses associated with any contingency are expensed as incurred. The Company’s officers and directors are not aware of any threatened or pending litigation to which the Company is a party or which any of its property is subject and which would have any material, adverse effect on the Company.

 

Item 1A. Risk Factors.

 

Reference is made to the risks and uncertainties disclosed in Item 1A (“Risk Factors”) of our Annual Report on Form 10-12G which sections are incorporated by reference into this report, as the same may be updated from time to time.

 

As a smaller reporting company, the Company is not required to disclose material changes to the risk factors.

 

Item 2. Unregistered Sales of Equity Securities and Use Of Proceeds.

 

During the three months ended March 31, 2026, the Company issued shares of common stock in connection with the conversion of Series B Preferred Stock, the settlement of debt and accrued interest obligations, compensation for consulting and professional services, financing fees, capital raising activities, and other corporate purposes. These issuances were completed pursuant to existing contractual arrangements, financing agreements, and the Company's ongoing efforts to strengthen its capital structure and support future growth initiatives.

 

As a result of these transactions, the Company's issued and outstanding common stock increased to 57,145,926 shares as of March 31, 2026.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

   

Not applicable.

 

Item 5. Other Information.

 

During the quarter ended March 31, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 

 29 

 

 

Item 6. Exhibits.

 

The exhibits listed on the Exhibit Index below are provided as part of this report.

 

Exhibit No.   Description
     
31.1*   Certification of principal executive and financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, as amended
     

32.1*

 

  Certification of principal executive officer and principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended
     
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted in IXBRL, and included in Exhibit 101.

 

______________

  * Filed herewith.

 

 

 

 

 

 

 

 

 

 

 

 30 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  KINETIC SEAS INCORPORATED
     
Dated: June 26, 2026 By: /s/ Edward Honour
    Edward Honour
   

Chief Executive Officer and
Chief Financial Officer

Principal Executive Officer,
Principal Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 31 

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

CERTIFICATION

CERTIFICATION

XBRL SCHEMA FILE

XBRL CALCULATION FILE

XBRL DEFINITION FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: kinetic_i10q-033126_htm.xml